cinobufotalin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hui, PP; Kai, S; Lu, JH; Zhao, H | 1 |
| Hua, BJ; Liu, X | 1 |
2 other study(ies) available for cinobufotalin and Adenocarcinoma
| Article | Year |
|---|---|
Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bufanolides; Cell Death; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Lactones; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering; Spiro Compounds; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
[Effect of traditional Chinese medicine on quality of life and survival period in patients with progressive gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Bufanolides; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Quality of Life; Retrospective Studies; Sesquiterpenes; Stomach Neoplasms; Survival Analysis; Survival Rate | 2008 |